Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Health Catalyst, Inc.
Report date June 01, 2026 · Filed June 03, 2026
Section 16 reporting ended · disclosed 2026-06-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 321,132 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Tax withholding · Disposed 8,519 · Balance 321,132 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 18, 2020 Filed Dec 22, 2020 01:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $10.04 | $0.00 |
DisclosureSEC source: 0001562180-20-007423 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2025-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 1000 shares underlying the options vested in an annual installment on June 1, 2016 and the remaining balance vested in equal monthly installments until the option vested in full on June 1, 2019. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 01:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001562180-20-007423 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 1,500 shares Expires 2026-10-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the 3,750 shares underlying the options vested in an annual installment on October 14, 2017 and the remaining balance vested in equal monthly installments until the option vested in full on October 14, 2020. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 01:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 500 | $6.24 | $3,120.00 |
DisclosureSEC source: 0001562180-20-007423 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 01:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 260 | $4.42 | $1,149.20 |
DisclosureSEC source: 0001562180-20-007423 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 01:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,000 | $10.04 | $10,040.00 |
DisclosureSEC source: 0001562180-20-007423 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 01:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,500 | $10.60 | $15,900.00 |
DisclosureSEC source: 0001562180-20-007423 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2020 Filed Dec 3, 2020 22:57 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 522 | $35.96 | $18,771.90 |
DisclosureSEC source: 0001562180-20-007059 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,918 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F4 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $35.50 to $36.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4). Read SEC document |
| December 02, 2020 Filed Dec 3, 2020 22:57 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,367 | $35.01 | $47,858.26 |
DisclosureSEC source: 0001562180-20-007059 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,440 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $34.50 to $35.49, inclusive. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:57 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,570 | $34.99 | $54,934.30 |
DisclosureSEC source: 0001562180-20-007059 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,807 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $34.88 to $35.09, inclusive. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:56 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,242 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-006551 · primarydocument.xml · derivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,999 Underlying: Common Stock · 2,242 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:56 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 200 | $34.37 | $6,874.00 |
DisclosureSEC source: 0001562180-20-006551 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:56 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,042 | $33.63 | $68,671.03 |
DisclosureSEC source: 0001562180-20-006551 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,577 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $33.28 to $34.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:56 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,242 | $10.80 | $24,213.60 |
DisclosureSEC source: 0001562180-20-006551 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,121 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-006231 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,241 Underlying: Common Stock · 1,121 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,121 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-006231 · primarydocument.xml · derivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,362 Underlying: Common Stock · 1,121 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 5 | $36.99 | $184.95 |
DisclosureSEC source: 0001562180-20-006231 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,237 | $36.37 | $81,359.69 |
DisclosureSEC source: 0001562180-20-006231 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,382 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $35.95 to $36.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,242 | $10.80 | $24,213.60 |
DisclosureSEC source: 0001562180-20-006231 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 23:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,121 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-005871 · primarydocument.xml · derivative · entry 7 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,955 Underlying: Common Stock · 1,121 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 23:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,121 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-005871 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,076 Underlying: Common Stock · 1,121 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 23:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 803 | $31.38 | $25,198.14 |
DisclosureSEC source: 0001562180-20-005871 · primarydocument.xml · nonDerivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.99 to $31.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 23:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 318 | $32.09 | $10,204.62 |
DisclosureSEC source: 0001562180-20-005871 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,180 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $32.07 to $32.13, inclusive. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 23:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,121 | $31.11 | $34,874.31 |
DisclosureSEC source: 0001562180-20-005871 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,498 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 23:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,121 | $10.80 | $12,106.80 |
DisclosureSEC source: 0001562180-20-005871 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 23:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,121 | $10.80 | $12,106.80 |
DisclosureSEC source: 0001562180-20-005871 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 23:10 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,242 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-005340 · primarydocument.xml · derivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,197 Underlying: Common Stock · 2,242 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 23:10 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,042 | $35.75 | $37,251.50 |
DisclosureSEC source: 0001562180-20-005340 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $35.54 to $35.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 23:10 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,200 | $35.21 | $42,252.00 |
DisclosureSEC source: 0001562180-20-005340 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,419 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $34.47 to $35.46, inclusive. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 23:10 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,242 | $10.80 | $24,213.60 |
DisclosureSEC source: 0001562180-20-005340 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:50 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,242 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-005001 · primarydocument.xml · derivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,439 Underlying: Common Stock · 2,242 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on September 25, 2022. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:50 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,221 | $29.97 | $36,593.37 |
DisclosureSEC source: 0001562180-20-005001 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $29.74 to $30.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:50 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,021 | $28.77 | $29,374.17 |
DisclosureSEC source: 0001562180-20-005001 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,598 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $28.52 to $29.42, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:50 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,242 | $10.80 | $24,213.60 |
DisclosureSEC source: 0001562180-20-005001 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:48 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,121 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-004416 · primarydocument.xml · derivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,681 Underlying: Common Stock · 1,121 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on September 25, 2022. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:48 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,121 | $30.00 | $33,630.00 |
DisclosureSEC source: 0001562180-20-004416 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:48 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,121 | $10.80 | $12,106.80 |
DisclosureSEC source: 0001562180-20-004416 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,121 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-004168 · primarydocument.xml · derivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,802 Underlying: Common Stock · 1,121 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on September 25, 2022. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,121 | $26.97 | $30,233.37 |
DisclosureSEC source: 0001562180-20-004168 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $26.70 to $27.35, inclusive. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,121 | $10.80 | $12,106.80 |
DisclosureSEC source: 0001562180-20-004168 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2020 Filed May 13, 2020 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,221 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-003583 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,923 Underlying: Common Stock · 2,221 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on September 25, 2022. Read SEC document |
| May 12, 2020 Filed May 13, 2020 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,221 | $30.00 | $66,630.00 |
DisclosureSEC source: 0001562180-20-003583 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. Read SEC document |
| May 12, 2020 Filed May 13, 2020 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,221 | $10.80 | $23,986.80 |
DisclosureSEC source: 0001562180-20-003583 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-003583 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,144 Underlying: Common Stock · 21 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on September 25, 2022. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 21 | $30.00 | $630.00 |
DisclosureSEC source: 0001562180-20-003583 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 21 | $10.80 | $226.80 |
DisclosureSEC source: 0001562180-20-003583 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:26 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,121 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-003395 · primarydocument.xml · derivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,165 Underlying: Common Stock · 1,121 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on September 25, 2022. Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:26 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 300 | $26.07 | $7,821.00 |
DisclosureSEC source: 0001562180-20-003395 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,377 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $26.04 to $26.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:26 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 821 | $25.20 | $20,689.20 |
DisclosureSEC source: 0001562180-20-003395 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,677 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $25.01 to $25.68, inclusive. Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:26 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,121 | $10.80 | $12,106.80 |
DisclosureSEC source: 0001562180-20-003395 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,121 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-002900 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,286 Underlying: Common Stock · 1,121 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on September 25, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.